The pace of progress of HPV vaccine introduction in Sub-Saharan francophone African countries has been limited, particularly in conflict-affected countries. To better understand the barriers affecting the introduction and sustainability of the HPV vaccine, we conducted a qualitative study from January – April 2024 informed by insights from a multi-country HPV symposium. Our study explored […]
Country: Central African Republic
Présentation des discussions au reste du groupe – Groupe 4
Le groupe 4 a traité des pays n’ayant pas encore intégré la vaccination anti-HPV. Les principaux défis incluent la méconnaissance des populations cibles, le manque de communication sur la maladie et le vaccin, l’insuffisance des ressources et des capacités techniques, ainsi que les problèmes d’accessibilité et d’insécurité dans certaines zones de conflit. Les opportunités comprennent […]
Breakout Groups Plenary feedback – Group 4
Group 4 discussed countries that have not yet integrated HPV vaccination into their programs. Main challenges include lack of accurate target population data, limited awareness and communication around the disease and vaccine, insufficient resources and technical capacity, and accessibility and security issues in conflict-affected areas. Opportunities include strong political will, existing reproductive health and adolescent […]